Power Law company profile

Confo Therapeutics

Biotech & Life Sciences · Ghent, Belgium · Founded 2015 Colt

Drug discovery platform targeting previously inaccessible GPCRs

Valuation

$100–500M

Latest valuation · 2026

Unlock exact value

Revenue

$50–100M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

16 investors on Confo Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage

Qbic Fund

Capricorn Partners

Series A 6 investors entered at this stage

Perceptive Advisors

Wellington Partners

The Institute for the Promotion of Innovation by Science and Technology in Flanders

BioGeneration Ventures

PMV

V-Bio Ventures

Series B+ 8 investors entered at this stage

Quest for Growth

Driehaus Capital Management

BioGenerator

University of Michigan

Vrije Universiteit Brussel

Ackermans & van Haaren

Flanders Institute for Biotechnology

FundPlus

Global footprint

Where Confo Therapeutics has talent and traffic

Workforce by country

🇧🇪 Belgium · Ghent HQ

Book a demo for the full country breakdown

Web traffic by country

7.9K monthly visits
across markets

🇧🇪 Belgium59.5%

🇺🇸 United States30.4%

🇮🇳 India11.4%

Top 3 markets shown

Market sentiment

What the market is saying about Confo Therapeutics

An AI-synthesized read of the highest-engagement posts about Confo Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Confo Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles